Eurogroup Review: “Habemus Papam” Eurogroup Review: “Habemus Papam” Eurogroup Review: “Habemus Papam”

Eurogroup Review: “Habemus Papam”

Macro
CD
Christopher Dembik

Head of Macro Analysis

Summary:  Following a lot of bilateral calls between Germany, France, Italy and the Netherlands, and one of the shortest plenary sessions in the history of the Eurogroup, yesterday evening, the finance ministers reached a compromise on the use of the ESM and agreed on the Commission's unemployment reinsurance scheme (SURE) and on EIB loans.


After a 48-hour saga and a very short plenary session that lasted only 32 minutes, the Eurogroup agreed to three safety nets (for workers, businesses and public finances) adding up to €540bn and opened the door to a recovery fund for the reconstruction phase that could be financed by “innovative” financial instruments (see here). However, inherited division from the sovereign debt crisis has not disappeared and the hardest part of the negotiations covering the recovery fund is yet to come.

Wopke Hoekstra, Dutch finance minister: “We are and will remain opposed to Eurobonds. We think this concept will not help Europe nor the Netherlands on the long term”.

Roberto Gualtieri, Italian finance minister: “We have put on the table of the European Council a Recovery Fund enabling common debt issuance. Off the table is any conditionality on the use of the ESM financing. Now it’s up to the leaders to take the right decisions”.

Bruno Le Maire, French finance minister : “the debate on debt mutualisation is on the table”.

Summit Results

  • The Eurogroup reached a consensus on the activation of the ESM with soft conditionality attached. It is capped at €240bn or 2% of member states’ GDP. The only requirement is that the credit line will focus on “direct and indirect” healthcare costs related to the COVID-19 and will end when the crisis is over. The terms still need to be agreed by the ESM governing bodies in the forthcoming days.
  • Support to businesses has been increased with extra financing through EIB loans, up to €200bn.
  • The Commission’s unemployment reinsurance scheme (SURE) has been adopted after assurance was given it would be temporary. The EU is allowed to borrow money in the market, up to €100bn, and will hand the funds to member states, without conditionality, in order to mitigate unemployment risks.
  • The finance ministers expressed willingness to explore “innovative” financial instruments to finance a recovery fund, without explicitly mentioning joint debt issuance.

Comment

Being objective, this is a very reasonable outcome. It required a lot of bilateral calls between the main players and Germany’s Olaf Scholz acting as a go-between to iron out differences regarding the ESM and SURE.  Politically, the compromise is very encouraging. Together with the ECB bazooka (PEPP) and national measures, the Eurogroup fiscal package should do the trick to mitigate the health crisis. It sets all the principles for future negotiations and a roadmap to follow in order to implement further measures. The following quote of Brian Tracy, a popular motivational public speaker, perfectly summarizes how the EU works: “The hardest part of any important task is getting started on it in the first place. Once you actually begin work on a valuable task, you seem to be naturally motivated to continue”. Remember Greece. It took three economic adjustment programs to deal with the situation. The EU has probably less time left, but there is no sense of urgency neither as the ECB is cleaning up all the secondary market in order to avoid tensions on sovereign bond yields.

Now, it is up to the EU27 leaders to give the final go and discuss some form of burden sharing and an exit management strategy. The hardest part is just to start. It is reassuring to see there is a consensus that the package so far on the table (EIB/ESM/SURE) and the existing instruments and institutions will not be enough to cope with the reconstruction phase that will begin, at the earliest, this summer. However, there is a clear disagreement between the Netherlands and Italy on what the “recovery fund” means. Clear guidance from the EU27 leaders to the Eurogroup will be needed in order to move forward fast on that issue.

In our view, it is unquestionable that coronabonds will come back. Some form of debt mutualization will be indispensable. Neither Italy nor Spain are in a position to raise the necessary funds for the reconstruction of their countries with new national debt alone. Germany needs to join forces with France for the common good and convince the Netherlands this is no time for egoism. If the European Union fails to show the necessary solidarity, countries from Southern Europe will not forget we have abandoned them, which will result in a definitive loss of confidence in the sense and credibility of the European project.

Quarterly Outlook 2024 Q3

Sandcastle economics

01 / 05

  • Macro: Sandcastle economics

    Invest wisely in Q3 2024: Discover SaxoStrats' insights on navigating a stable yet fragile global economy.

    Read article
  • Bonds: What to do until inflation stabilises

    Discover strategies for managing bonds as US and European yields remain rangebound due to uncertain inflation and evolving monetary policies.

    Read article
  • Equities: Are we blowing bubbles again

    Explore key trends and opportunities in European equities and electrification theme as market dynamics echo 2021's rally.

    Read article
  • FX: Risk-on currencies to surge against havens

    Explore the outlook for USD, AUD, NZD, and EM carry trades as risk-on currencies are set to outperform in Q3 2024.

    Read article
  • Commodities: Energy and grains in focus as metals pause

    Energy and grains to shine as metals pause. Discover key trends and market drivers for commodities in Q3 2024.

    Read article
You can access both of our platforms from a single Saxo account.
Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-hk/about-us/awards.

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.